Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02837705 · ClinicalTrials.gov registry record
Therapeutic Antibodies Against Prion Diseases From PRNP Mutation Carriers
A clinical trial, sponsored by University of Zurich.
- Completed
- Registry status
- 213
- Enrollment target
NCT02837705 is a clinical trial that has completed, run by University of Zurich. The registered enrollment target is 213 participants.
The verdict
NCT02837705 has completed, sponsored by University of Zurich.
- COMPLETED
- Registry status
- 213 participants
- Enrollment target
Study Summary
The human Prion diseases can be classified into sporadic, acquired and inherited forms. Inherited forms usually manifest in higher age so there have to be factors preventing Prion propagation in young mutation carriers. Antibodies against the flexible tail of Prions have been shown to be protective in mice. The investigators intend to screen mutation carriers and controls for the presence of Prion autoantibodies.
Interventions
- OTHER blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 2015-09-01 |
| Est. Completion | 2019-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02837705
The ClinicalTrials.gov registry entry for NCT02837705 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 213 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Zurich, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which blood draw is the first listed.
NCT02837705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02837705 about?
NCT02837705 is a clinical study titled "Therapeutic Antibodies Against Prion Diseases From PRNP Mutation Carriers". The human Prion diseases can be classified into sporadic, acquired and inherited forms. Inherited forms usually manifest in higher age so there have to be factors preventing Prion propagation in young mutation carriers. Antibodies against the flexible tail of Prions have been shown to be protective ...
What is the current status of trial NCT02837705?
This trial is currently completed. The enrollment target is 213 participants. The study started on 2015-09-01. Estimated completion is 2019-03-01.
What interventions are being tested in trial NCT02837705?
The interventions under investigation include: blood draw (OTHER).
Who is sponsoring clinical trial NCT02837705?
This trial is sponsored by University of Zurich, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.